E. K. Artemov
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
E. K. Artemov has a total of 25 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Erovichenkov
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences; Russian Medical Academy of Postgraduate Education
1 shared publication Academician I.P. Pavlov First St. Petersburg State Medical University of the Ministry of Healthcare of the Russian Federation
1 shared publication- Alexsander V. Lyashko
Gamaleya National Research Center for Epidemiology and Microbiology
1 shared publication - Anastasia Piniaeva
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow 108819, Russia
1 shared publication - Aydar A. Ishmukhametov
Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products of Russian Academy of Sciences (Institute of Poliomyelitis), Moscow 108819, Russia
1 shared publication - Boris I. Timofeev
National Research Center for Epidemiology and Microbiology named after honorary academician N.F. Gamaleya
1 shared publication
Latest Publications
- 1 January 2022
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 11 (1)
Determination of antibodies to SARS-CoV-2 in patients with coronavirus infection
Определение антител к вирусу SARS-СoV-2 у пациентов с новой коронавирусной инфекцией
- 1 January 2022
- Published by Geotar-Media Publishing Group in Infectious diseases: News, Opinions, Training
- Vol. 11 (1)
Determination of antibodies to SARS-CoV-2 in patients with coronavirus infection
Определение антител к вирусу SARS-СoV-2 у пациентов с новой коронавирусной инфекцией
- Open Access
- 9 July 2021
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 66 (3) , 189-197
Monoclonal antibodies to hemagglutinin of influenza A/H7N3 virus (Orthomyxoviridae: Alphainfluenzavirus: Influenza A virus)
Introduction. Variants of influenza virus A/H7 have the same high pandemic potential as A/H5. However, the information about the antigenic structure of H7 hemagglutinin (НА) is considerably inferior in quantitative terms to similar data for H5 НА.The aims of the study were development and characterization of the monoclonal antibodies (MAbs) panel for HA subtype H7 of the influenza A virus.Material and methods. Viruses were accumulated in 10-day-old chicken embryos. Purification and concentration of the virus, determination of protein concentration, preparation of MAbs and ascitic fluids, hemagglutination and hemagglutination inhibition (HI) tests, assessment of antibodies’ activity in indirect enzyme-linked immunosorbent assay (ELISA), as well as determination of MAbs isotypes and neutralization reaction (NR) were carried out by standard methods.Results. The obtained MAbs to А/mallard/Netherlands/12/2000 (H7N3) strain were studied in HI test with a set of strains of different years of isolation belonging to different evolutionary groups. MAbs had a reduced reactivity compared to the immunogen-virus for all the studied strains. Cross-interaction of MAbs 9E11 and 9G12 in HI test with influenza A/H15 virus has been observed.Discussion. Influenza A agent with H7 HA variant could serve as a potential cause of a future pandemic. Development of the MAbs panel for subtype H7 HA is an urgent task for both veterinary medicine and public health.Conclusion. The obtained MAbs can be used not only for epitope mapping of the H7 HA molecule (currently insufficiently studied) and as reagents for diagnostic assays, but also for determining common («universal») epitopes in HA of different strains of this subtype.
- 9 July 2021
- Published by Central Research Institute for Epidemiology in Problems of Virology
- Vol. 66 (3) , 189-197
Open AccessMonoclonal antibodies to hemagglutinin of influenza A/H7N3 virus (Orthomyxoviridae: Alphainfluenzavirus: Influenza A virus)
Introduction. Variants of influenza virus A/H7 have the same high pandemic potential as A/H5. However, the information about the antigenic structure of H7 hemagglutinin (НА) is considerably inferior in quantitative terms to similar data for H5 НА.The aims of the study were development and characterization of the monoclonal antibodies (MAbs) panel for HA subtype H7 of the influenza A virus.Material and methods. Viruses were accumulated in 10-day-old chicken embryos. Purification and concentration of the virus, determination of protein concentration, preparation of MAbs and ascitic fluids, hemagglutination and hemagglutination inhibition (HI) tests, assessment of antibodies’ activity in indirect enzyme-linked immunosorbent assay (ELISA), as well as determination of MAbs isotypes and neutralization reaction (NR) were carried out by standard methods.Results. The obtained MAbs to А/mallard/Netherlands/12/2000 (H7N3) strain were studied in HI test with a set of strains of different years of isolation belonging to different evolutionary groups. MAbs had a reduced reactivity compared to the immunogen-virus for all the studied strains. Cross-interaction of MAbs 9E11 and 9G12 in HI test with influenza A/H15 virus has been observed.Discussion. Influenza A agent with H7 HA variant could serve as a potential cause of a future pandemic. Development of the MAbs panel for subtype H7 HA is an urgent task for both veterinary medicine and public health.Conclusion. The obtained MAbs can be used not only for epitope mapping of the H7 HA molecule (currently insufficiently studied) and as reagents for diagnostic assays, but also for determining common («universal») epitopes in HA of different strains of this subtype.